Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement
Authors:
Open Access
- 23 April 2015
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-6
Abstract
Innovative catheter systems with lower-profile sheaths and a dynamic expansion mechanism (DEM) were recently introduced for transcatheter aortic valve replacement (TAVR). However, the labeling of 14 F and 16 F eSheaths denote the inner nominal diameter. Exact changes of the clinically relevant outer diameters during usage are not available. eSheaths were measured every 30 mm using a digital caliper. Unused 14 F and 16 F eSheaths served as controls. Maximum eSheath diameters were measured after insertion of the Edwards Commander Delivery System (ECDS) into 14 F and 16 F eSheaths.Finally, eSheaths were retrieved and measured after TAVR. Outer diameters of control 14 F eSheaths were 5.8 mm and 6.50 mm for the 16 F eSheath. Introduction of the 23 mm and 26 mm ECDS into 14 F eSheaths showed a maximum diameter of 7.65 mm and 7.64 mm (). Introduction of the 29 mm ECDS into the 16 F eSheath showed the greatest diameter of 8.18 mm (). After TAVR, diameters of the 14 F eSheaths were 7.14 mm (23 mm valve) and 7.26 mm (26 mm valve) (), while 16 F eSheaths were 8.10 mm (29 mm valve) (). Nominal 14 F and 16 F eSheaths showed a significant increase of the outer diameter during advancement of the ECDS and after TAVR implantation.
Keywords
This publication has 11 references indexed in Scilit:
- Descending aortic dissection injured by tip of the sheath during transcatheter aortic valve implantationCardiovascular Intervention and Therapeutics, 2015
- Expandable sheath for transfemoral transcatheter aortic valve replacement: Procedural outcomes and complicationsCatheterization and Cardiovascular Interventions, 2014
- Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacementEuroIntervention, 2013
- Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve ImplantationJACC, 2013
- Management of Vascular Access in Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2013
- Incidence, Predictors, and Implications of Access Site Complications With Transfemoral Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2012
- Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJACC, 2012
- First‐in‐man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT ValveCatheterization and Cardiovascular Interventions, 2012
- Improvements in Transcatheter Aortic Valve Implantation Outcomes in Lower Surgical Risk PatientsJACC, 2012
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010